SEMA3C and glioblastoma: In conclusion, our results revealed that overexpression of Sema3C significantly inhibited GBM-associated tumorigenesis and angiogenesis processes in a CAM model and enhanced the inhibitory effect of therapeutic agent NaVP on GBM cell invasion and adhesion processes.